RIKEN | Jotup

Japanese joint research group win Prime Minister's Award with ultra high-performance computing platform using jointly developed 64-qubit quantum computer

Retrieved on:

Friday, March 15, 2024

AIST, RIKEN, Research, Fujitsu, Communication, NTT, Osaka University, NICT, Microscope

The platform leverages Japan's second domestically-made 64-qubit superconducting quantum computer, which has been offered on the cloud since October 2023 to promote its use for commercial industrial research and development, and jointly developed by Fujitsu and RIKEN based on the know-how for the development of the first domestically-made 64-qubit superconducting quantum computer released in March 2023 by the joint research group.

Key Points:

The platform leverages Japan's second domestically-made 64-qubit superconducting quantum computer, which has been offered on the cloud since October 2023 to promote its use for commercial industrial research and development, and jointly developed by Fujitsu and RIKEN based on the know-how for the development of the first domestically-made 64-qubit superconducting quantum computer released in March 2023 by the joint research group.
The research group offered Japan's first superconducting quantum computer under a joint research agreement for non-commercial use for the purpose of promoting and developing research and development in quantum computation and other fields.
RIKEN and Fujitsu also unveiled Japan's second superconducting quantum computer, based on the technology of the first superconducting quantum computer, on the cloud for industrial research and development in 2021, two and a half years after they established the RIKEN RQC-Fujitsu Collaboration Center.
RIKEN and Fujitsu's superconducting quantum computer is provided as part of a hybrid quantum computing platform that also supports Fujitsu's 40-qubit quantum simulator, which remains one of the largest scale simulators in the world.

Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji

Retrieved on:

Wednesday, February 14, 2024

Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan.

Key Points:

Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan.
Hideyoshi Fuji has been appointed Representative Director of Iktos K.K., and Vice-President, Japan Business Development and Operations.
Hideyoshi, 42, spent 13 years at Astellas Pharma Inc. (2009-2021) as an expert in computational chemistry and chemoinformatics.
After his career with Astellas Pharma, Hideyoshi became an entrepreneur in 2022 and supported business development and marketing efforts in Japan for overseas software companies.

Fujitsu AI strategy strengthens data integration, generative AI capabilities with dedicated platform and new Fujitsu Uvance offerings

Retrieved on:

Wednesday, February 14, 2024

Tokyo Institute of Technology, Research, Tohoku University, Azure, Health, Language, Microsoft Azure, RIKEN, LLM, Meta, Trust, Creativity, Platform as a service, Machine learning, Microsoft, Environment, Medical device

As a global leader in AI, Fujitsu has been promoting the research and development of innovative AI and machine learning technologies for over 30 years, and continues to embrace recent breakthroughs in areas like generative AI.

Key Points:

As a global leader in AI, Fujitsu has been promoting the research and development of innovative AI and machine learning technologies for over 30 years, and continues to embrace recent breakthroughs in areas like generative AI.
Fujitsu is also currently developing its own generative AI technology specializing in image and code generation, as well as generative AI mixture technology that integrates Fujitsu's generative AI models with generative AI models from partner companies efficiently.
Fujitsu confirmed that the accuracy of these generative AI models is equal to or higher than that of state-of-the-art generative AI models including GPT-4V and HuggingGPT.
To encourage creative experimentation and further development of AI technologies, Fujitsu has also created an environment in which all of its 124,000 global employees can securely use generative AI.

Fujitsu announces winners of the Fujitsu quantum simulator challenge

Retrieved on:

Thursday, January 25, 2024

A64FX, QEC, Delft University of Technology, Research, Noise, University, HPC, Ambiguity, Algorithm, Insurance, FUJITSU, RIKEN, Microscope

TOKYO, Jan 25, 2024 - (JCN Newswire) - Fujitsu from February to September 2023 conducted the "Fujitsu $100,000 Quantum Simulator Challenge," a global competition in which Fujitsu called members of the industry and academia to test Fujitsu's 39 qubit quantum simulator on novel problems and applications.

Key Points:

TOKYO, Jan 25, 2024 - (JCN Newswire) - Fujitsu from February to September 2023 conducted the "Fujitsu $100,000 Quantum Simulator Challenge," a global competition in which Fujitsu called members of the industry and academia to test Fujitsu's 39 qubit quantum simulator on novel problems and applications.
Fujitsu plans to hold the quantum simulator challenge again in 2024 and beyond, utilizing an enhanced quantum simulator with 40 qubits, one of the largest in the world (3).
Hideto Okada, Head of Technology Strategy Unit, Fujitsu, comments:
"Participants of the quantum simulator challenge have developed various advanced applications using Fujitsu's quantum simulator.
As feedback from users of quantum simulators represents an important key in the development of quantum applications, Fujitsu opened up some of its quantum simulator resources to the public and started the "Fujitsu $100,000 Quantum Simulator Challenge" to gain feedback from participating research institutions, universities, and companies competing for quantum application development in various fields.

RIKEN Selects Quantinuum System Model H1 for Large-Scale Hybrid Quantum-Supercomputing Platform in Japan

Retrieved on:

Wednesday, January 10, 2024

NEDO, New energy, Research, Computational science, SoftBank Group, University, Computer, Osaka University, University of Tokyo, HPC, NISQ, Ministry, RIKEN, Television

BROOMFIELD, Colo. and LONDON, Jan. 10, 2024 /PRNewswire/ -- Quantinuum, the world's largest integrated quantum computing company, and RIKEN, Japan's largest comprehensive research institution and home to a world-leading high-performance computing (HPC) center, have announced an agreement in which Quantinuum will provide access to Quantinuum's highest performing H1-Series ion-trap quantum computing technology to RIKEN. Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.

Key Points:

Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.
The deployment will be part of RIKEN's project to build a quantum-HPC hybrid platform consisting of high-performance computing systems, such as the supercomputer Fugaku and quantum computers.
As the project goal, RIKEN and its collaborators aim to demonstrate the advantages of such hybrid computational platforms for deployment as services in the future post-5G era.
"We are honored to be selected to be part of this ambitious, advanced project in Japan," said Dr. Rajeeb Hazra, CEO of Quantinuum.

Machine learning techniques improve X-ray materials analysis

Retrieved on:

Friday, November 17, 2023

Machine learning, RIKEN, Science, Weakness, Quality control, Water, Light, Electron, Medical imaging

Analysis of materials can be done quicker and with less expertise with the help of proven machine learning techniques established in biomedical fields.

Key Points:

Analysis of materials can be done quicker and with less expertise with the help of proven machine learning techniques established in biomedical fields.
The new method was published in the journal Science and Technology of Advanced Materials: Methods.
The team's solution was to use machine learning methods established in biomedical fields in combination with a transfer learning technique to finely adjust to the segmentation analysis of SR-CTs.
Building on the existing machine learning model greatly reduced the amount of training data needed to get results.

VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through Third-Party Allotment.

Retrieved on:

Wednesday, November 15, 2023

VCCT Inc.(President: Masayo Takahashi) is pleased to announce the completion of a private equity allotment of approximately 600 million yen ($4 million USD).

Key Points:

VCCT Inc.(President: Masayo Takahashi) is pleased to announce the completion of a private equity allotment of approximately 600 million yen ($4 million USD).
With the completion of this fundraising round, the total amount of funds raised by VCCT now amounts to 1.7 billion yen ($11.3 million USD).
VCCT is dedicated to the development and application of cutting-edge cell therapy treatments focusing on retinal diseases.
As a front runner in regenerative medicine research, VCCT has accumulated a wealth of clinical expertise in this field.

Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins

Retrieved on:

Tuesday, October 10, 2023

Based on these two technologies, the two parties developed an AI drug discovery technology that can predict structural changes of a protein in a wide range, with the aim of developing next-generation IT drug discovery technology that significantly reduces the development time and cost of drug discovery.

Key Points:

Based on these two technologies, the two parties developed an AI drug discovery technology that can predict structural changes of a protein in a wide range, with the aim of developing next-generation IT drug discovery technology that significantly reduces the development time and cost of drug discovery.
Moving forward, Fujitsu and RIKEN will use the newly developed generative AI technology as one of the core technologies for realizing next-generation IT drug discovery technology that can analyze the complex relationships between target proteins and antibodies, and predict global structural changes of molecules with high accuracy and speed.
To solve this problem, Fujitsu and RIKEN have developed the following two new drug discovery technologies using generative AI.
Using generative AI technology, Fujitsu and RIKEN analyzed the low-dimensional data and predicted the conformational changes by restoring 3D density maps.

Fujitsu and RIKEN develop superconducting quantum computer at the RIKEN RQC-Fujitsu Collaboration Center, paving the way for platform for hybrid quantum computing

Retrieved on:

Thursday, October 5, 2023

Algorithm, CCSD, RIKEN, Quantum, HPC, Fujitsu, Environment, Software, Drug discovery, Acceleration, NISQ, Noise, Research, Computer, Microscope

The new quantum computer leverages the technology developed by RIKEN and a consortium of joint research partners including Fujitsu for Japan's first superconducting quantum computer, which was first revealed to the public in March 2023.

Key Points:

The new quantum computer leverages the technology developed by RIKEN and a consortium of joint research partners including Fujitsu for Japan's first superconducting quantum computer, which was first revealed to the public in March 2023.
Accompanying this announcement, Fujitsu and RIKEN further revealed the launch of a platform for hybrid quantum computing, which combines the computing power of the newly developed 64 qubit superconducting quantum computer with one of the world's largest (1) 40 qubit quantum computer simulators developed by Fujitsu.
Fujitsu and RIKEN are further developing a hybrid quantum algorithm that links superconducting quantum computing with high-performance computing (HPC).
To address these issues, Fujitsu and RIKEN have launched a new hybrid quantum computing platform that combines the advantages of superconducting quantum computers and quantum simulators, ultimately contributing to further usage of the superconducting quantum computer developed at the RIKEN RQC-Fujitsu Collaboration Center and the development of new quantum applications.

SPIE Photonics West 2024 Opens for Registration

Retrieved on:

Thursday, October 5, 2023

Metaverse, Hardware, Technology, Semiconductor, Security, Satellite, Photography, Science, Engineering, Manufacturing, Telecommunications, Other Science, Bloomberg Global Business Forum, Health, Multimedia, Entertainment Industries Council, RIKEN, Texas A&M University, University of Maryland, College Park, Boston University, META, Instrument, Therapy, Moscone Center, University of Stuttgart, University College London, LMU, Oppo, Information, Exhibition, University, Massachusetts General Hospital, University of California, Systems biology, University of California, Davis, Magic Leap, Harvard Medical School, Quantum computing, BIOS, AR, Hot Topic, University of Tokyo, Duke University, Bangladesh Technical Education Board, Princeton University, Photoacoustic imaging, JILA, Dartmouth–Hitchcock Medical Center, National Institutes of Health, Research, BOS, Video game, Microscope, Nursing, SPIE, Kernel

Registration has opened for SPIE Photonics West 2024 , which will run from 27 January to 1 February at the Moscone Center in San Francisco.

Key Points:

Registration has opened for SPIE Photonics West 2024 , which will run from 27 January to 1 February at the Moscone Center in San Francisco.
View the full release here: https://www.businesswire.com/news/home/20231005492002/en/
Attendees at SPIE Photonics West 2023 (Photo: Business Wire)
SPIE Photonics West has four major application areas emphasizing the latest technologies and discoveries that utilize optics and photonics.
All three exhibitions and the industry program are free to attend with a SPIE Photonics West registration.
“Photonics West 2024 promises to be an engaging and thought-provoking week of networking and learning opportunities,” said SPIE Senior Director of Technical Programs Marilyn Gorsuch.